Denial of Eye Closure in Acute Stroke
Stroke 25:1958-1962, Ellis,S.J.&Small,M., 1994
Anterior Operculum Syndrome
Neurol 39:1169-1172, Mao,C.C.,et al, 1989
Stroke Mechanism and Severity after Left Atrial Appendage Occlusion, Insights from the LAAOS III Randomized Clinical Trial
JAMA Neurol 83:76-82, Katsanos,A.H.,et al, 2026
Stroke Associated with Patent Foramen Ovale(PFO): Evaluation
www.UptodDate.com, Dec 2025, Messe,S.R., 2025
Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
NEJM 384:2081-2091,2154, Whitlock, R.P.,et al, 2021
Immunocompetent Patient with Multiple Cranial Nerve Palsies, Ataxia, and Cognitive Decline
Neurol 94:e225-e229, Nigam, M.,et al, 2020
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018
PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018
Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy
Stroke 47:e190-e192, Stoker, T.B.,et al, 2016
Ocular Motor Abnormalities in Bilateral Paramedian Thalamic Stroke
Neurol 84:e155-e158, Gooneratne, I.K.,et al, 2015
Left Atrial Appendage Function and Stroke Risk
Stroke 46:3554-3559, Yaghi, S.,et al, 2015
Percutaneous Left Atrial Appendage Closure:Technical Aspects and Prevention of Periprocedural Complications with the Watchman Device
Workd J Cardiol 26:65-75, Mobius-Winkler,S.,et al, 2015
Clinicopathologic Conference, Cerebral Granulomatosis with Polyangiitis
NEJM 371:162-173, Case 21-2014, 2014
Clinicopathologic Conference, Lemierres Syndrome
NEJM 371:2018-2027, Case Record 36-2014, 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Clinicopathologic Conference, Squamous- Cell Carcinoma of the Tongue with Metastasis to Lungs, Liver, Bone of Skull, Trigeminal Nerve, Base of Skull, Pituitary Gland and Dura Matter. Infarcts of Cerebellum and Right Frontal Lobe.
NEJM 367:1136-1145, Case 29-2012, 2012
Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Stroke 43:3147-3149, Thaler, D.E.,et al, 2012
A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011
Closure of Patent Foramen Ovale After Cryptogenic Stroke
Lancet 368:350-352, Wrle,J., 2006
Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006
Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004
A ripping roller coaster ride
Neurol 61:1255, Blacker, D.J. & Wijdicks, E.F.M., 2003
Ptosis in Patients with Hemispheric Strokes
Neurol 58:620-624, Averbuch-Heller,L.,et al, 2002
A Practical Approach to the Diagnosis and Management of MELAS: Case Report and Review
The Neurologist 8:302-312, Thambisetty,M.,et al, 2002
Closure of Patent Foramen Ovale for Pardoxical Emboli: Intermediate-Term Risk of Recurrent Neurological Events Following Transcatheter Device Placement
J Am Coll Cardiol 35:1311-1316, Hung,J.,et al, 2000
Subjective Experience and Behavior in Acute Stroke,The Lausanne Emotion in Acute Stroke Study
Neurol 52:22-28, Ghika-Schmid,F.,et al, 1999
Pontine Anosognosia for Hemiplegia
Neurol 53:647-649, Evyapan,D.&Kumral,E., 1999
Headache: Cortical Vein Thrombosis and Response to Anticoagulation
J Emerg Med 17:449-453, Minadeo,J.P &Karaman,B.A., 1999
Localization of Lesion in Denial of Hemiplegia After Acute Stroke
Stroke 28:67-71, Ellis,S.&Small,M., 1997
Bilateral Ptosis and Upgaze Palsy with Right Hemispheric Lesions
Ann Neurol 40:465-468, Averbuch-Heller,L.,et al, 1996
Subjective Experiences of 24 Patients Dramatically Recovering from Stroke
Stroke 26:1285-1288, Grotta,J.&Bratina,P., 1995
Mitochondrial DNA and Disease
NEJM 333:638-644, Johns,D.R., 1995
Pure Midbrain Infarction:Clinical Syndromes, MRI, and Etiologic Patterns
Neurol 44:2032-2040, Bogousslavsky,J.,et al, 1994
Denial of Illness in Stroke
Stroke 24:757-759, Ellis,S.J.&Small,M., 1993